Not every pulmonary embolism is treated the same way, and one of the most important factors separating a routine case from an urgent one is whether the right side of the heart is under strain. Right heart strain in PE signals that the clot burden is large enough, or positioned centrally enough, to raise pressure in the pulmonary arteries and challenge the right ventricle's ability to pump against it. Recognizing this finding early reshapes the entire management conversation.
Why the Right Ventricle Is Vulnerable in PE
The right ventricle is a thin-walled chamber built to pump blood into a normally low-pressure pulmonary circulation. When a pulmonary embolism obstructs a significant portion of that circulation, pulmonary artery pressure rises abruptly, and the right ventricle — unlike the more muscular left ventricle — is poorly adapted to handle a sudden increase in afterload. This mismatch is why even a moderate clot burden can produce meaningful right heart strain if it is positioned to significantly obstruct flow.
How Is Right Heart Strain Detected?
Clinicians look for right heart strain through a combination of imaging and blood-based biomarkers. Echocardiography can show right ventricular dilation, reduced wall motion, or a bulging interventricular septum, all suggesting the right ventricle is struggling against elevated pressure. CT pulmonary angiography, the imaging study most often used to diagnose PE in the first place, can also reveal right ventricular enlargement relative to the left ventricle — a ratio commonly reviewed by radiologists as one of several CT signs of strain. Blood tests measuring troponin and brain natriuretic peptide (BNP) provide a complementary signal, since elevated levels can reflect right ventricular stress even before overt dysfunction is visible on imaging.
Why Does This Finding Change Management?
The presence of right heart strain generally reclassifies a PE from low-risk toward the intermediate-risk category, sometimes described as submassive PE when strain is present but blood pressure remains stable. This distinction matters because intermediate-risk PE carries a meaningfully different management conversation than a small, uncomplicated clot. Anticoagulation alone may still be appropriate for many of these patients, but the presence of strain often prompts closer monitoring, and in select cases, consideration of escalation to catheter-directed therapy or thrombectomy if the patient's condition shows signs of deteriorating. This is one of the key inputs a pulmonary embolism response team weighs when triaging a case.
What Happens if Strain Progresses Toward Instability?
If right heart strain progresses to the point where blood pressure drops or the patient shows signs of shock, the case is generally reclassified as high-risk or massive PE, a category that more strongly supports urgent intervention. The trajectory — whether strain is stable, improving, or worsening on serial assessment — often matters as much as the initial finding itself, which is why patients with intermediate-risk PE are typically monitored closely rather than treated with anticoagulation and simply discharged.
Device-Based Options When Strain Warrants Escalation
When right heart strain is significant enough to prompt escalation beyond anticoagulation, catheter-based aspiration thrombectomy or catheter-directed thrombolysis may be considered to reduce clot burden more rapidly than medication alone. These decisions are made by the treating team based on the individual patient's hemodynamic status and imaging findings. An overview of the device categories used in this pathway, including large-bore aspiration systems, is available on INVAMED's pulmonary embolism management page.
Does right heart strain resolve after PE treatment?
In many patients, right ventricular function improves as the clot burden is reduced, whether through anticoagulation alone or more active intervention, though the pace and completeness of recovery vary. Follow-up imaging is often used to confirm that right heart function has normalized over time.
Device availability and regulatory status vary by country. Please contact INVAMED or your authorized local distributor for current regulatory information applicable to your region.